A 24-wk, prospective, d/b [double-blind], placebo controlled, parallel group, multicenter, randomized/withdrawal efficacy and safety study of dexloxiglumide for the relief of symptoms in patients with constipation-predominant irritable bowel syndrome
Latest Information Update: 01 Dec 2009
At a glance
- Drugs Dexloxiglumide (Primary)
- Indications Constipation; Irritable bowel syndrome
- Focus Therapeutic Use
- Acronyms DARWIN
- 19 Nov 2005 New trial record.